Peptidyl arginine deiminase type 2 (PAD-2) and PAD-4 but not PAD-1, PAD-3, and PAD-6 are expressed in rheumatoid arthritis synovium in close association with tissue inflammation-Reference-Cited by-同舟云学术

Peptidyl arginine deiminase type 2 (PAD-2) and PAD-4 but not PAD-1, PAD-3, and PAD-6 are expressed in rheumatoid arthritis synovium in close association with tissue inflammation

Published:2007 Issue:11 Volume:56 Page:3541-3553
ISSN:0004-3591
Container-title:Arthritis & Rheumatism
language:en
Short-container-title:Arthritis Rheum

Author:

Foulquier Céline,Sebbag Mireille,Clavel Cyril,Chapuy-Regaud Sabine,Al Badine Roula,Méchin Marie-Claire,Vincent Christian,Nachat Rachida,Yamada Michiyuki,Takahara Hidenari,Simon Michel,Guerrin Marina,Serre Guy

Publisher

Wiley

Subject

Pharmacology (medical),Immunology,Rheumatology,Immunology and Allergy

Reference51 articles.

1. Autoantibodies to citrullinated proteins: ACPA

2. In the rheumatoid pannus, anti-filaggrin autoantibodies are produced by local plasma cells and constitute a higher proportion of IgG than in synovial fluid and serum

3. The Major Synovial Targets of the Rheumatoid Arthritis-Specific Antifilaggrin Autoantibodies Are Deiminated Forms of the α- and β-Chains of Fibrin

4. Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis-specific autoantibodies.

Cited by 313 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Peptidylarginine deiminase (PAD): A promising target for chronic diseases treatment;International Journal of Biological Macromolecules;2024-10

2. Recognition and control of neutrophil extracellular trap formation by MICL;Nature;2024-08-14

3. Unveiling Novel Drug Targets and Emerging Therapies for Rheumatoid Arthritis: A Comprehensive Review;ACS Pharmacology & Translational Science;2024-05-28

4. Protein Citrullination by Peptidyl Arginine Deiminase/Arginine Deiminase Homologs in Members of the Human Microbiota and Its Recognition by Anti-Citrullinated Protein Antibodies;International Journal of Molecular Sciences;2024-05-10

5. Iguratimod inhibits protein citrullination and inflammation by downregulating NBCe2 in patients with rheumatoid arthritis;Biomedicine & Pharmacotherapy;2024-05